BILIX

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark BILIX was filed as Word mark on 11/11/2020 at the World Intellectual Property Organization.

Trademark Details Last update: August 11, 2023

Trademark form Word mark
File reference 1571295
Countries Australia Canada China European Community United Kingdom Japan United States of America (USA)
Base trademark KR No. , November 20, 2024
Application date November 11, 2020
Expiration date November 11, 2030

Trademark owner

12th Fl., 364, Gangnam-daero, Gangnam-gu
Seoul
KR

Trademark representatives

#1402, Kolon Digital Tower Aston Bldg, 212, Gasan Digital 1-Ro, Geumcheon-Gu KR

goods and services

05 Pharmaceuticals; medicines for human purposes; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical products; diagnostic preparations for medical or veterinary purposes; enzymes for medical purposes; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; medicines for dental purposes; medicines for intestinal disorders; ophthalmic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; vaccines; immunoassay reagents for medical use
42 Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; scientific investigations for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consulting on the test, inspection and research of medical products; providing information on the test, inspection and research of medical products; industrial research in the fields of medicine, health and pharmacology; engineer services in the medical technology

Trademark history

Date Document number Area Entry
December 9, 2022 2022/50 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 11, 2022 2022/33 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 10, 2022 2022/19 Gaz CA Rejection
December 16, 2021 2021/50 Gaz JP Rejection
June 10, 2021 2021/24 Gaz EM Rejection
May 31, 2021 2021/23 Gaz CN Rejection
May 27, 2021 2021/21 Gaz GB Rejection
April 26, 2021 2021/17 Gaz US Rejection
April 23, 2021 2021/16 Gaz AU Rejection
November 11, 2020 2021/1 Gaz KR Registration

ID: 141571295